The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

BetterLife Pharma Inc. + Watchlist Alert BETRF US Closed Last Updated: May 23, 2025 9:55 a.m. EDT Delayed quote $ 0.0810-0.0033-3.91% Previous Close $0.0843 Toggle Chart Options Advanced Charting ...

Vinod Nair, Head of Research, Geojit Financial Services, sheds light on the Indian stock market and how the IT sector and Pharmaceutical stocks are set to outperform in the ‘near term.’ ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group ...

Yunnan Baiyao Group Co. Ltd. A-0.21% ¥100.77B Tasly Pharmaceutical Group Co. Ltd. A-0.87% ¥23.78B Jiangsu Hengrui Pharmaceuticals Co. Ltd. A-1.62% ¥346.04B Zhejiang Hisun Pharmaceutical Co. Ltd ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ji’an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya® (dihydroergotamine mesylate ...

Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food and Drug Administration. Patients told Reuters they have turned to ...